(Q36560767)

14 August 2017

1 reference

title

Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful? (English)

1 reference

14 August 2017

1 reference

1

C G M Kallenberg

1 reference

14 August 2017

C A Stegeman

2

1 reference

14 August 2017

H Bootsma

series ordinal

3

1 reference

14 August 2017

M Bijl

series ordinal

4

1 reference

14 August 2017

P C Limburg

series ordinal

5

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

15

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

397-402

1 reference

Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

The key role of nucleosomes in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Measurement of anti-DNA antibodies: a reappraisal using five different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Anti-dsDNA: choice of assay in relation to clinical value

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Anti-dsdna and complement profiles as prognostic guides in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2323OA

10.1191/0961203306LU2323OA

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference